HCA Holdings Inc. Stock
Price
Target price
€447.10
€447.10
-1.890%
-8.6
-1.890%
€447.67
24.02.26 / Tradegate
WKN: A1JFMW / Symbol: HCA / Name: HCA Holdings / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
HCA Holdings Inc. Stock
A loss of -1.890% shows a downward development for HCA Holdings Inc..
The stock is an absolute favorite of our community with 42 Buy predictions and no Sell predictions.
However, we have a potential of -0.02% for HCA Holdings Inc. as the target price of 447 € is below the current price of 447.1 €.
Criterium "Revenue growth" is seen as the biggest plus for HCA Holdings Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of HCA Holdings Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of HCA Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| HCA Holdings Inc. | -1.890% | 0.509% | 14.135% | 50.281% | 12.860% | 91.290% | 213.517% |
| Anthem Inc. | -3.090% | -2.697% | -9.207% | -22.596% | -3.193% | -37.854% | 13.682% |
| Quest Diagnostics Inc. | -0.200% | 0.716% | 14.855% | 7.289% | 17.935% | 30.936% | 81.340% |
| Universal Health Services B | -0.510% | 0.000% | 13.793% | 14.451% | 3.125% | 42.734% | 78.378% |
Comments
HCA Healthcare (NYSE:HCA) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $635.00 price target on the stock.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Argus from $530.00 to $560.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat
HCA Healthcare (NYSE:HCA) had its price target raised by analysts at Leerink Partners from $507.00 to $573.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for HCA provided by MarketBeat
